Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
82%
Graft-versus-host Disease (GvHD)
69%
Pretransplant
60%
Confidence Interval
49%
Immune Response
31%
Nonmyeloablative
30%
Non-myeloablative Transplantation
30%
Hematopoietic Cell Transplantation
24%
Immune Parameters
23%
Non-relapse Mortality
22%
Myeloablative
20%
Vitamin E
20%
Working Party
20%
Transplant Complications
20%
Hepatocellular Carcinoma
20%
Obesity
20%
Hospitalized COVID-19 Patients
20%
Hematopoietic Stem Cell Transplantation
18%
COVID-19
16%
Whole Blood
15%
Risk Factors
15%
Patients with Obesity
14%
Hazard Ratio
14%
Immune Reconstitution
13%
Cytokine Response
13%
Overall Survival
13%
Interleukin-10
11%
Denmark
11%
TruCulture
11%
Hospitalization
11%
Multi-cohort Studies
11%
Allogeneic Transplantation
11%
Disease Relapse
11%
Platelets
11%
Epidemiology
11%
Europe
10%
Acute Myeloid Leukemia
10%
Cytomegalovirus Infection
10%
Bloodstream Infection
10%
Cure Model
10%
Ocular Chronic Graft-versus-host Disease
10%
Vitamin D Status
10%
Improved Survival
10%
Population-based Study
10%
Graft-versus-host Disease Prophylaxis
10%
Danish Population
10%
Acute Lymphoblastic Leukemia
10%
Single Center
10%
HLA-matched Donor
10%
Plasma Vitamin D
10%
Immunology and Microbiology
Cell Transplantation
100%
Hematopoietic Cell
100%
Acute Graft Versus Host Disease
61%
COVID-19
30%
Allogeneic Hematopoietic Stem Cell Transplantation
27%
Immune Response
24%
Immunocompetent Cell
21%
Vitamin E
20%
Transplant Procedure
20%
Hemocyte
20%
Blood Plasma
17%
Overall Survival
16%
Chronic Graft Versus Host Disease
15%
Conditioning
14%
Vitamin Blood Level
14%
Hematopoietic Stem Cell Transplantation
13%
Allotransplantation
11%
Platelet
11%
Immune Reconstitution
11%
Cytokine Response
11%
Cytokine
11%
Graft-Versus-Host Disease
10%
Cytomegalovirus Infection
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Vaccine Efficacy
10%
Erythrocyte
10%
Prognostic Biomarker
10%
Autoantibodies
10%
Gram-Negative Bacteria
10%
Cell Population
10%
Phenotype
10%
Mycophenolic Acid
8%
Nonmyeloablative Stem Cell Transplantation
5%
Ciclosporin
5%
Sirolimus
5%
B Cell
5%
T Cell
5%
Mortality
5%
Medicine and Dentistry
Cell Transplantation
70%
Hematopoietic Stem Cell
70%
Acute Graft Versus Host Disease
58%
Allogeneic Hematopoietic Stem Cell Transplantation
21%
Hepatocellular Carcinoma
20%
Alpha Tocopherol
20%
Human Immunodeficiency Virus
20%
Transplantation
20%
Hazard Ratio
19%
Cohort Analysis
17%
Chronic Graft Versus Host Disease
15%
Overall Survival
15%
Acute Myeloid Leukemia
11%
Cohort Effect
11%
Allotransplantation
10%
Graft Versus Host Reaction
10%
Bloodstream Infection
10%
Geriatric Oncology
10%
Acute Lymphoblastic Leukemia
10%
Vitamin D
10%
Nurse
10%
Erythrocyte Transfusion
10%
Hepatitis B Virus
10%
Erythrocyte
10%
Hepatitis C Virus
10%
Tenofovir
10%
Platelet
10%
Hypomethylating Agent
10%
Diabetes
10%
Prophylaxis
10%
Mycophenolic Acid
8%
Nonmyeloablative Stem Cell Transplantation
5%
Cyclosporine
5%
Rapamycin
5%
Tenofovir Disoproxil
5%
Cumulative Incidence
5%
Mortality
5%
